Effect of TLR4 and B7-H1 on immune escape of urothelial bladder cancer and its clinical significance

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 3, 2014, Pages 1321-1326

  Wang, Yong Hua ^a   Cao, Yan Wei ^a   Yang, Xue Cheng ^a   Niu, Hai Tao ^a   Sun, Li Jiang ^a   Wang, Xin Sheng ^a   Liu, Jing ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

B7 H1; Immune escape; Toll like receptor 4; Urothelial bladder cancer

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2-(2-AMINO-3-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; BLOCKING ANTIBODY; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CD274 PROTEIN, HUMAN; FLAVONOID; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; PDCD1 PROTEIN, HUMAN; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN KINASE INHIBITOR; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 4;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; BLADDER TUMOR; COCULTURE; CYTOTOXIC T LYMPHOCYTE; DRUG ANTAGONISM; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE; TUMOR ESCAPE; UROTHELIUM;

ANTIBODIES, BLOCKING; ANTIGENS, CD274; APOPTOSIS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CELL LINE, TUMOR; COCULTURE TECHNIQUES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FLAVONOIDS; GENE EXPRESSION; HUMANS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; PROGRAMMED CELL DEATH 1 RECEPTOR; PROTEIN KINASE INHIBITORS; T-LYMPHOCYTES, CYTOTOXIC; TOLL-LIKE RECEPTOR 4; TUMOR ESCAPE; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84896829364     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.3.1321     Document Type: Article

References (27)

1. Ayari C, Bergeron A, LaRue H, et al (2011). Toll-like receptors in normal and malignant human bladders. J Urol, 2011, 185, 1915-21.
2. Babjuk M, Burger M, Zigeuner R, et al (2013). EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013. Eur Urol, 64, 639-53.
3. Biragyn A, Ruffini PA, Leifer CA, et al (2002). Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science, 298, 1025-9.
4. Blank C, Brown I, Peterson AC, et al (2004). PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells. Cancer Res, 64, 1140-5.
5. Dong H, Strome SE, Salomao DR, et al (2002). Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med, 8, 793-800.
6. Elhag OA, Hu XJ, Wen-Ying Z, et al (2012). Reconstructed adeno-associated virus with the extracellular domain of murine PD-1 induces antitumor immunity. Asian Pac J Cancer Prev, 13, 4031-6.
7. Ghebeh H, Mohammed S, Al-Omair A, et al (2006). The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia, 8, 190-8.
8. Gong XH, Wang YH, Shao SX, et al (2013). Role of TLR4-signaling pathway in the immune evasion of bladder cancer and its mechanism. Chin J Cancer Prev Treat, 20, 1217-20.
9. Hasan A, Ghebeh H, Lehe C, et al (2011). Therapeutic targeting of B7-H1 in breast cancer. Expert Opin Ther Targets, 15, 1211-25.
10. Herr HW, Bean MA, Whitmore WF Jr (1976). Decreased ability of blood leukocytes from patients with tumors of the urinary bladder to act as stimulator cells in mixed leukocyte culture. Cancer Res, 36, 2754-60.
11. Huang B, Zhao J, Li H, et al (2005). Toll-Like Receptors on Tumor Cells Facilitate Evasion of Immune Surveillance. Cancer Res, 65, 5009-14.
12. Inman BA, Sebo TJ, Frigola X, et al (2007). PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCGinduced granulomata: associations with localized stage progression. Cancer, 109, 1499-505.
13. Iwai Y, Ishida M, Tanaka Y, et al (2002). Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci USA, 99, 12293-7.
14. Kaufman DS, Shipley WU, Feldman AS (2009). Bladder cancer. Lancet, 374, 239-49.
15. Konishi J, Yamazaki K, Azuma M, et al (2004). B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin Cancer Res, 10, 5094-100.
16. Liu J, Hamrouni A, Wolowiec D, et al (2007). Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway. Blood, 110, 296-304.
17. Loskog A, Ninalga C, Paul-Wetterberg G, et al (2007). Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines. J Urol, 177, 353-8.
18. Mukamel E, Shohat B, Servadio C (1982). Immunological profile of patients with transitional cell carcinoma of the bladder. Br J Urol, 54, 11-5.
19. Okudaira K, Hokari R, Tsuzuki Y, et al (2009). Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model. Int J Oncol, 35, 741-9.
20. Patard JJ, Saint F, Velotti F, et al (1998). Immune response following intravesical Bacillus Calmette-Guerin instillations in superficial bladder cancer: a review. Urol Res, 26, 155-9.
21. Qian Y, Deng J, Geng L, et al (2008). TLR4 signaling induces B7-H1 expression through MAPK pathways in bladder cancer cells. Cancer Invest, 26, 816-21.
22. Song J, Abraham SN (2008). TLR-mediated immune responses in the urinary tract. Curr Opin Microbiol, 11, 66-73.
23. Sun Q, Liu Q, Zheng Y, et al (2008). Rapamycin suppresses TLR4-triggered IL-6 and PGE2 production of colon cancer cells by inhibiting TLR4 expression and NF-kappa B activation. Mol lmmunol, 45, 2929-36.
24. Thompson RH, Kuntz SM, Leibovich BC, et al (2006). Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res, 66, 3381-5.
25. Tsujihashi H, Matsuda H, Uejima S, et al (1989). Immunoresponse of tissue infiltrating lymphocytes in bladder tumors. J Urol, 141, 1467-70.
26. Vabulas RM, Wagner H, Schild H (2002). Heat shock proteins as ligands of toll-like receptors. Curr Top Microbiol Immunol, 270, 169-84.
27. Zhang D, Zhang G, Hayden MS, et al (2004). A toll-like receptor that prevents infection by uropathogenic bacteria. Science, 303, 1522-6.